These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 21985443)

  • 1. In vitro efficacy of some cattle drugs on bovine serum paraoxonase 1 (PON1) activity.
    Arslan M; Gencer N; Arslan O; Guler OO
    J Enzyme Inhib Med Chem; 2012 Oct; 27(5):722-9. PubMed ID: 21985443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Purification of PON1 from human serum and assessment of enzyme kinetics against metal toxicity.
    Ekinci D; Beydemir S
    Biol Trace Elem Res; 2010 Jun; 135(1-3):112-20. PubMed ID: 19727574
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel purification strategy for human PON1 and inhibition of the activity by cephalosporin and aminoglikozide derived antibiotics.
    Sinan S; Kockar F; Arslan O
    Biochimie; 2006 May; 88(5):565-74. PubMed ID: 16600468
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro inhibition effect of some coumarin compounds on purified human serum paraoxonase 1 (PON1).
    Gokce B; Gencer N; Arslan O; Karatas MO; Alici B
    J Enzyme Inhib Med Chem; 2016 Aug; 31(4):534-7. PubMed ID: 25982292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impacts of some antibiotics on human serum paraoxonase 1 activity.
    Dilek EB; Küfrevioğlu Öİ; Beydemir Ş
    J Enzyme Inhib Med Chem; 2013 Aug; 28(4):758-64. PubMed ID: 22591317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro inhibition effect of some dihydroxy coumarin compounds on purified human serum paraoxonase 1 (PON1).
    Erzengin M; Basaran I; Cakir U; Aybey A; Sinan S
    Appl Biochem Biotechnol; 2012 Nov; 168(6):1540-8. PubMed ID: 22971832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of some antibiotics on paraoxonase from human serum in vitro and from mouse serum and liver in vivo.
    Sinan S; Kockar F; Gencer N; Yildirim H; Arslan O
    Biol Pharm Bull; 2006 Aug; 29(8):1559-63. PubMed ID: 16880604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigation of heavy metal effects on immobilized paraoxanase by glutaraldehyde.
    Bilen Ç; Beyaztaş S; Arslan O; Güler ÖÖ
    J Enzyme Inhib Med Chem; 2013 Jun; 28(3):440-6. PubMed ID: 22233542
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antidepressant and antipsychotic drugs differentially affect PON1 enzyme activity.
    Avcikurt AS; Sinan S; Kockar F
    J Enzyme Inhib Med Chem; 2015 Apr; 30(2):245-9. PubMed ID: 24934243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Some coumarins and benzoxazinones as potent paraoxonase 1 inhibitors.
    Karataş MO; Uslu H; Alıcı B; Gökçe B; Gencer N; Arslan O
    J Enzyme Inhib Med Chem; 2016 Dec; 31(6):1386-91. PubMed ID: 26887799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Some cardiovascular therapeutics inhibit paraoxonase 1 (PON1) from human serum.
    Işgör MM; Beydemir S
    Eur J Pharmacol; 2010 Oct; 645(1-3):135-42. PubMed ID: 20670621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiepileptic drugs: Impacts on human serum paraoxonase-1.
    Beydemir Ş; Demir Y
    J Biochem Mol Toxicol; 2017 Jun; 31(6):. PubMed ID: 28032682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Some indazoles reduced the activity of human serum paraoxonase 1, an antioxidant enzyme:
    Alım Z; Kılıç D; Demir Y
    Arch Physiol Biochem; 2019 Dec; 125(5):387-395. PubMed ID: 29741961
    [No Abstract]   [Full Text] [Related]  

  • 14. Naringenin is an inhibitor of human serum paraoxonase (PON1): an in vitro study.
    Mahrooz A; Rashidi MR; Nouri M
    J Clin Lab Anal; 2011 Nov; 25(6):395-401. PubMed ID: 22086792
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Paraoxonase-1 and linoleic acid oxidation in familial hypercholesterolemia.
    van Himbergen TM; van Tits LJ; Hectors MP; de Graaf J; Roest M; Stalenhoef AF
    Biochem Biophys Res Commun; 2005 Aug; 333(3):787-93. PubMed ID: 15963464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and paroxonase activities of novel bromophenols.
    Akbaba Y; Türkeş C; Polat L; Söyüt H; Sahin E; Menzek A; Göksu S; Beydemir S
    J Enzyme Inhib Med Chem; 2013 Oct; 28(5):1073-9. PubMed ID: 22994801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the impacts of antibiotic drugs on PON 1; a major bioscavenger against cardiovascular diseases.
    Ekinci D; Beydemir S
    Eur J Pharmacol; 2009 Sep; 617(1-3):84-9. PubMed ID: 19577563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antioxidant effect of atorvastatin is independent of PON1 gene T(-107)C, Q192R and L55M polymorphisms in hypercholesterolaemic patients.
    Sardo MA; Campo S; Bonaiuto M; Bonaiuto A; Saitta C; Trimarchi G; Castaldo M; Bitto A; Cinquegrani M; Saitta A
    Curr Med Res Opin; 2005 May; 21(5):777-84. PubMed ID: 15969877
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human plasma paraoxonase 1 (PON1) arylesterase activity during aging: correlation with susceptibility of LDL oxidation.
    Mehdi MM; Rizvi SI
    Arch Med Res; 2012 Aug; 43(6):438-43. PubMed ID: 22959975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Purification human PON1Q192 and PON1R192 isoenzymes by hydrophobic interaction chromatography and investigation of the inhibition by metals.
    Gençer N; Arslan O
    J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Jan; 877(3):134-40. PubMed ID: 19084484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.